Croma-Pharma Announces FDA Approval of Obagi saypha® ChIQ™ in the United States

Contributed by: Business Wire

Logo

Tags

Cosmetics

Retail

Health

FDA

Other Health

Pharmaceutical

Biotechnology

More Like This

PR Newswire associated0

Croma-Pharma GmbH Celebrates FDA Approval of Obagi saypha® MagIQ™ in the United States

Croma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast

PR Newswire associated0

Novaestiq Unveils Platform of Innovations; Poised to Disrupt the US Aesthetic Market

Croma Skincare – Where Science Meets Skin

Croma-Pharma Acquires Synocrom™ and Returns to Orthopaedics

Croma Pharma Launches AI-Driven Tech Venture to Revolutionize Aesthetic Medicine via Clinicore Platform

IMCAS 2026: Galderma Showcases the Latest Scientific Advances Behind the Industry’s Broadest Injectable Aesthetics Portfolio

AMWC Dubai: Galderma Demonstrates Injectable Aesthetics Leadership Through Updates on Its Scientific Innovations and Community Education